MCL coexpression mm9:140
From FANTOM5_SSTAR
Phase1 CAGE Peaks
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
| GO ID | GO name | FDR corrected p-value |
|---|---|---|
| GO:0009057 | macromolecule catabolic process | 0.0247987635291779 |
| GO:0006096 | glycolysis | 0.0247987635291779 |
| GO:0015898 | amiloride transport | 0.0247987635291779 |
| GO:0016024 | CDP-diacylglycerol biosynthetic process | 0.0247987635291779 |
| GO:0050164 | oxoglutarate dehydrogenase (NADP+) activity | 0.0247987635291779 |
| GO:0030303 | stromelysin 2 activity | 0.0247987635291779 |
| GO:0030161 | calpain inhibitor activity | 0.0247987635291779 |
| GO:0046341 | CDP-diacylglycerol metabolic process | 0.0247987635291779 |
| GO:0006007 | glucose catabolic process | 0.0247987635291779 |
| GO:0046365 | monosaccharide catabolic process | 0.0247987635291779 |
| GO:0019320 | hexose catabolic process | 0.0247987635291779 |
| GO:0009056 | catabolic process | 0.0247987635291779 |
| GO:0046164 | alcohol catabolic process | 0.0247987635291779 |
| GO:0008654 | phospholipid biosynthetic process | 0.0247987635291779 |
| GO:0044275 | cellular carbohydrate catabolic process | 0.0247987635291779 |
| GO:0004605 | phosphatidate cytidylyltransferase activity | 0.0247987635291779 |
| GO:0045634 | regulation of melanocyte differentiation | 0.0247987635291779 |
| GO:0042587 | glycogen granule | 0.0247987635291779 |
| GO:0004105 | choline-phosphate cytidylyltransferase activity | 0.0247987635291779 |
| GO:0050932 | regulation of pigment cell differentiation | 0.0247987635291779 |
| GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity | 0.0247987635291779 |
| GO:0016052 | carbohydrate catabolic process | 0.0247987635291779 |
| GO:0046467 | membrane lipid biosynthetic process | 0.0247987635291779 |
| GO:0048038 | quinone binding | 0.0304929991876725 |
| GO:0030060 | L-malate dehydrogenase activity | 0.0304929991876725 |
| GO:0030976 | thiamin pyrophosphate binding | 0.0304929991876725 |
| GO:0006006 | glucose metabolic process | 0.0364354278864612 |
| GO:0060158 | dopamine receptor, phospholipase C activating pathway | 0.0364354278864612 |
| GO:0006651 | diacylglycerol biosynthetic process | 0.0364354278864612 |
| GO:0016779 | nucleotidyltransferase activity | 0.0406319751788347 |
| GO:0006108 | malate metabolic process | 0.0412564231525579 |
| GO:0008131 | amine oxidase activity | 0.0412564231525579 |
| GO:0006644 | phospholipid metabolic process | 0.044031454269364 |
| GO:0006656 | phosphatidylcholine biosynthetic process | 0.0465750754568059 |
| GO:0019318 | hexose metabolic process | 0.0485965440168064 |
| GO:0046460 | neutral lipid biosynthetic process | 0.0485965440168064 |
| GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor | 0.0485965440168064 |
| GO:0046463 | acylglycerol biosynthetic process | 0.0485965440168064 |
| GO:0005996 | monosaccharide metabolic process | 0.0490593965590794 |
| GO:0016615 | malate dehydrogenase activity | 0.0490593965590794 |
| GO:0046504 | glycerol ether biosynthetic process | 0.0490593965590794 |
| GO:0045017 | glycerolipid biosynthetic process | 0.0490593965590794 |
| GO:0046339 | diacylglycerol metabolic process | 0.0490593965590794 |
Relative expression of the co-expression cluster over median <br>Analyst:
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br><br>
| Ontology term | p-value | n |
|---|---|---|
| intestine | 3.94e-34 | 31 |
| gastrointestinal system | 9.20e-26 | 47 |
| small intestine | 6.95e-12 | 4 |
| mucosa | 7.68e-11 | 15 |
| digestive system | 1.30e-10 | 116 |
| digestive tract | 1.30e-10 | 116 |
| primitive gut | 1.30e-10 | 116 |
| endoderm-derived structure | 2.42e-10 | 118 |
| endoderm | 2.42e-10 | 118 |
| presumptive endoderm | 2.42e-10 | 118 |
| ileal mucosa | 5.76e-09 | 3 |
| ileum | 5.76e-09 | 3 |
| mucosa of small intestine | 5.76e-09 | 3 |
| wall of small intestine | 5.76e-09 | 3 |
| subdivision of digestive tract | 9.84e-09 | 114 |
| organ component layer | 5.08e-08 | 24 |
| intestinal mucosa | 3.03e-07 | 13 |
| anatomical wall | 3.03e-07 | 13 |
| wall of intestine | 3.03e-07 | 13 |
| gastrointestinal system mucosa | 3.03e-07 | 13 |
TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
| Motifs | -log10(p-value) |
|---|---|
|
{{{tfbs_overrepresentation_jaspar}}} |
